logo/base Created with Sketch.

FibroScan® Included in Key International Guidelines

Join this webinar to learn more about the pivotal role of noninvasive tests, including VCTE™, for earlier identification and risk stratification of at-risk patients.

Dr. Mazen Noureddin and Dr. Naim Alkhouri will review and discuss the patient clinical care pathways now recommended by the main Gastroenterology and Diabetology guidelines (including AASLD, EASL, AGA and AACE) and how to optimize patient management as NASH-dedicated therapies are on the horizon.​​​​​


>> Register Now <<


Mazen Noureddin, MD, MHSc
Director of the Houston Research Institute Houston, TX
Naim Alkhouri, MD
Chief Medical Officer, Chief of Transplant Hepatology and Director of Fatty Liver Program at the Arizona Liver Health (ALH) Phoenix, AZ
chevron Register Now